Aspirin

Basic Information

CAS ID:	50-78-2
Molecular Formula:	C9H8O4
Molecular Weight:	180.2 g/mol
Monoisotopic Mass:	180.0423 g/mol
Class:	Small Molecule
Natural Product:	No
Other Names:	Acetosalic Acid \| POSTMI 300 \| PAYNOCIL \| LEVIUS \| Equi-Prin \| ENPRIN \| DISPRIN CV \| ANADIN ALL NIGHT \| Ecotrin \| DURLAZA \| BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN \| 8-HOUR BAYER \| NU-SEALS 600 \| DANAMEP \| ASPRO CLR \| ALKA RAPID \| Aspirin \| NU-SEALS CARDIO 75 \| MICROPIRIN EC \| ANGETTES 75 \| MEASURIN \| Lysine Acetylsalicylate \| PLATET \| POSTMI 75 \| ACETYLSALIC ACID \| DISPRIN DIRECT \| GENCARDIA \| NU-SEALS 75 \| MAX STRGH ASPRO CLR \| NU-SEALS 300 \| PLATET 300 \| ACETYLSALICYLIC ACID \| Salicylic Acid Acetate
Analysis:	Drug repositioning mechanism analysis

Compound Structure and Identifier

InChI:	InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)	See All
InChI Key:	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
Smiles:	CC(=O)Oc1ccccc1C(=O)O	See All
Molfile:	Download

Related Target

Related Fibrosis Property

Reference Record 1

PubMed ID	21783632	Target ID
Uniprot ID		Name
Model	vitro	Fibrosis Disease	Fibrosis
Process I
Process II
Process III
Mechanism

Trial Record 1

ClinicalTrial ID	NCT02744716	Disease	Scar
Phase	Not Applicable	Status	Completed
First Received	April 20, 2016	Last Verified	April 20, 2016
Sponsor	First Affiliated Hospital, Sun Yat-Sen University

Trial Record 2

ClinicalTrial ID	NCT02247414	Disease	Liver fibrosis
Phase	Phase 4	Status	Completed
First Received	September 25, 2014	Last Verified	November 6, 2017
Sponsor	Yangzhou University

Trial Record 3

ClinicalTrial ID	NCT02238444	Disease	Liver fibrosis
Phase	Phase 4	Status	Recruiting
First Received	September 12, 2014	Last Verified	January 1, 2019
Sponsor	Yangzhou University

Related Link

PubChem:	2244
ChEMBL:	CHEMBL25